The 2023 United Nations (UN) High-Level Meeting (HLM) on Tuberculosis (TB) saw world leaders come together to commit to increased
TB Alliance wholeheartedly supports the commitment made today at the United Nations High-Level Meeting on Tuberculosis (TB) to fight this
Four years ago, TB Alliance secured the first regulatory approval from the United States Food and Drug Administration (US FDA)
19 December 2022: Viatris, a global healthcare company, MedAccess, and TB Alliance have announced a new agreement to reduce the
PRETORIA (16 November, 2022)—A new study published in PLOS Global Public Health found that the BPaLM/BPaL treatment regimen that will
Results of ZeNix Trial Show Effectiveness of BPaL Regimen for Highly Drug-Resistant TB Can Be Maintained with Reduced Dosing of
New Guidelines Have Potential to Transform the TB Treatment Landscape with Six-Month Standard PRETORIA (3 May 2022)—TB Alliance applauds today’s
Imagining a TB-free world amidst resurgence during COVID-19 pandemic NEW YORK (March 24, 2022)—The world continues to battle against two
Unfortunately, the recent history of the tuberculosis (TB) pandemic has in large part been defined by neglect—inadequate funding for research
PRETORIA (24 March 2021)—On World TB Day, as society reflects on how COVID-19 became the world’s most lethal infection in the
